Mutations in ARID1A, SMARCD1, and ZNF429 were either hotspot mutations (ARID1A and ZNF429) or had functional relevance (inactivating mutations in tumor suppressor SMARCD1) (https://cancer.sanger.ac.uk/cosmic/mutation)26. This evidence concerns the gene ARID1A and neoplasm.